Cargando…
The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
Glucocorticoids therapy has greatly improved the outcome of lupus nephritis patients. Since their discovery, their adverse effects have counterbalanced their beneficial anti-inflammatory effects. Glucocorticoids exert their effects through both genomic and non-genomic pathways. Differential activati...
Autores principales: | Mejía-Vilet, Juan M., Ayoub, Isabelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921306/ https://www.ncbi.nlm.nih.gov/pubmed/33665199 http://dx.doi.org/10.3389/fmed.2021.622225 |
Ejemplares similares
-
New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
por: Zavala-Miranda, María Fernanda, et al.
Publicado: (2021) -
Old and New Calcineurin Inhibitors in Lupus Nephritis
por: Ponticelli, Claudio, et al.
Publicado: (2021) -
The Network of Inflammatory Mechanisms in Lupus Nephritis
por: Nozaki, Yuji
Publicado: (2020) -
Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021) -
Analysis of the safety and efficacy of tacrolimus combined with glucocorticoid in the treatment of lupus nephritis
por: Li, Lu, et al.
Publicado: (2022)